Cognitive and behavioural assessments in clinical trials: what type of measure?
β Scribed by Gus A Baker; Anthony G Marson
- Book ID
- 108460343
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 58 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0920-1211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (
The aim of this cost-effectiveness study was to compare a combined operant programme plus cognitive/relaxation programme with an operant programme plus attention-control and to compare both programmes with a waiting-list control group and with operant rehabilitation provided, as usual, by the same r